Myriad Genetics (MYGN) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 2.45% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.12% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -53.05% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.64% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.08% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 78.37% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 49.22% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.69% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -16.05% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -37.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.02% |
| Sep 30, 2025 | -63.01% |
| Jun 30, 2025 | -94.85% |
| Mar 31, 2025 | 61.74% |
| Dec 31, 2024 | 97.39% |
| Sep 30, 2024 | 75.27% |
| Jun 30, 2024 | 42.23% |
| Mar 31, 2024 | -11.30% |
| Dec 31, 2023 | -51.21% |
| Sep 30, 2023 | 70.40% |
| Jun 30, 2023 | -82.51% |
| Mar 31, 2023 | 77.57% |
| Sep 30, 2022 | 56.87% |
| Jun 30, 2022 | -156.89% |
| Mar 31, 2022 | -159.27% |
| Dec 31, 2021 | 141.76% |
| Sep 30, 2021 | -413.20% |
| Jun 30, 2021 | -38.26% |
| Mar 31, 2021 | -36.87% |
| Dec 31, 2020 | -54.42% |